Equity Overview
Price & Market Data
Price: $0.0066
Daily Change: $0.00 / 0.00%
Daily Range: $0.0066 - $0.008
Market Cap: $530,537
Daily Volume: 18,100
Performance Metrics
1 Week: 266.7%
1 Month: 230.0%
3 Months: 450.0%
6 Months: 91.30%
1 Year: 69.23%
YTD: 450.0%
Details
Aequus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. The company offers ZIMED PF, a preservative-free bimatoprost prescription drug for the for the reduction of elevated interocular pressure in patients with open angle glaucoma or ocular hypertension. It also develops REV-0100, which is in pre-clinical trial for the treatment of stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.